NDC11 71209009004
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 71209-0090-04 | 71209-0090 |
| 71209-0090-4 | 71209-0090 |
| 71209-090-04 | 71209-090 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Atorvastatin Calcium | ATORVASTATIN CALCIUM | Cadila Pharmaceuticals Limited | 51730b09-24e8-41c8-9fec-813f8a64b433 | 2024-05-28 | Warnings, Adverse reactions | 71209-090-04 71209-090 71209009004 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.